| Measure Code | Measure Title | Performance Rate | Patient Count | Star Value | Five Star Benchmark | Collection Type |
|---|---|---|---|---|---|---|
| IA_EC_BE_4 | Engagement of patients through implementation of improvements in patient portal | |||||
| IA_EC_CC_2 | Implementation of improvements that contribute to more timely communication of test results | |||||
| IA_EC_PSPA_1 | Participation in an AHRQ-listed patient safety organization. | |||||
| IA_EC_PSPA_16 | Use of decision support and standardized treatment protocols | |||||
| MIPS_EC_005_overall | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) | 90 | 51 | EHR | ||
| MIPS_EC_001_overall | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | 52 | 61 | EHR | ||
| MIPS_EC_007_overall | Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) | 100 | 34 | EHR | ||
| MIPS_EC_008_overall | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) | 100 | 48 | EHR | ||
| MIPS_EC_110_overall | Preventive Care and Screening: Influenza Immunization | 71 | 482 | 4 | 85 | EHR |
| MIPS_EC_119_overall | Diabetes: Medical Attention for Nephropathy | 85 | 61 | 4 | 100 | EHR |
| MIPS_EC_130_overall | Documentation of Current Medications in the Medical Record | 89 | 1244 | 4 | 100 | EHR |
| MIPS_EC_236_overall | Controlling High Blood Pressure | 72 | 333 | EHR | ||
| MIPS_EC_317_overall | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented | 29 | 484 | 2 | 64 | EHR |
| MIPS_EC_318_overall | Falls: Screening for Future Fall Risk | 89 | 552 | 4 | 100 | EHR |